PDS BIOTECHNOLOGY CORP

FLORHAM PARK, NJ How do I update this listing?

PDS Biotechnology Corp is based out of Florham Park. Edge Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company discovers, develops, and seek to commercialize hospital-based therapies for the management of acute, life-threatening neurological conditions. Edge Therapeutics serves customers worldwide.Whalewisdom has at least 78 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-04-09. The notice included securities offered of Equity

Create Alert

Contact Info

pds biotechnology corp
25B VREELAND ROAD
FLORHAM PARK NJ    07932

Business Phone: 800-208-3343
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-04-09 D PHARMACEUTICALS Equity 56,000,000 55,999,978 22
2014-11-13 D PHARMACEUTICALS Equity 25,000,000 7,937,236 17,062,764
2013-03-25 D PHARMACEUTICALS Equity 20,000,000 6,673,405 13,326,595
2012-09-17 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 3,000,000 118,500 2,881,500
2011-06-24 D PHARMACEUTICALS Equity 2,750,000 219,500 2,530,500
2010-11-08 D/A OTHER HEALTH CARE Equity,Other 2,000,000 634,500 1,365,500
2009-09-16 D OTHER HEALTH CARE Equity,Other 2,000,000 500,000 1,500,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALBERT N. MARCHIO II subscription required
    EXECUTIVE OFFICER
ANDREW EINHORN subscription required
    EXECUTIVE OFFICER
BERT MARCHIO subscription required
    EXECUTIVE OFFICER PROMOTER
BRIAN LEUTHNER subscription required
    EXECUTIVE OFFICER DIRECTOR PROMOTER
CARL J. SORANNO subscription required
    DIRECTOR
CARL SORRANO subscription required
    DIRECTOR PROMOTER
HERBERT J. FALECK subscription required
    EXECUTIVE OFFICER
ISAAC BLECH subscription required
    DIRECTOR
JAMES J. LOUGHLIN subscription required
    DIRECTOR
KURT CONTI subscription required
    DIRECTOR
LEUTHNER A. BRIAN subscription required
    EXECUTIVE OFFICER DIRECTOR
PRIYA JAMBHEKAR subscription required
    EXECUTIVE OFFICER
R LOCH MCDONALD subscription required
    EXECUTIVE OFFICER DIRECTOR PROMOTER
R. LOCH MACDONALD subscription required
    DIRECTOR
ROBERT LOCH MACDONALD subscription required
    EXECUTIVE OFFICER DIRECTOR PROMOTER
ROBERT SPIEGEL subscription required
    DIRECTOR
SOL BARER subscription required
    DIRECTOR

Elevate your investments